I can see how this might be helpful to the wider world, but how...

I can see how this might be helpful to the wider world, but how does this help Auscann?

They are not the cultivator (Medipharm Labs use bulk biomass)
They are not the extractor (Medipharm Labs is and holds the patents around extraction technique)
They are not the manufacturer of the hard shell capsule (PCI in Melbourne is and hold the patent around this technology)

Even if they show that if you take X mg of CBD, you receive Y mg in your bloodstream, Auscann is not the beneficiary of this and can not charge a margin it. This seems like a zero dollar value proposition.